Articles
| Open Access |
DOI: Management Of A Patient With A Rare Variant Of Autoimmune Polyglandular Syndrome Of The Second Type
Negmatova Gulzoda Shuhratovna , Samarkand State Medical Institute, Samarkand, Republic Of UzbekistanAbstract
The article considers a clinical case of a young patient with autoimmune polyglandular
syndrome type 2, represented by type 1 diabetes mellitus, thyroid dysfunction and
primary adrenal cortex insufficiency.
Keywords
autoimmune polyglandular syndrome type 2,, type 1 diabetes mellitus
References
Betterle C., Zanchetta R. Update on autoimmune polyendocrine syndromes (APS).
Clinical Immunology and Allergology. Acta Bio Medica 2003; 74: 1: 9-33.
Kahaly G.J. Polyglandular autoimmune syndromes. Eur J Endocrinol 2009; 161: 1: 11-
doi: 10.1530/eje-09-0044.
Endocrinology. National leadership. Edited By I. I. Dedov, G. A. Melnichenko. M:
GEOTAR-Media, 2008.
Yu. I. Klyuchagina1, Z. A. Sokolova2, M. A. Baryshnikov2. The role of the PD-1 receptor
and its PDL1 and PDL2 ligands in tumor immunotherapy. Oncopediatrics. 2017, 4 (1) 49-
pages.
L. Tsarev , A.V. Melerzanov, Review of approaches to immunotherapy in Oncology.
Journal of Research and practice in medicine 2017, vol. 4, no. 3, pp. 51-65 REVIEW DOI:
Article Statistics
Copyright License
Copyright (c) 2020 The American Journal of Medical Sciences and Pharmaceutical Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.